PLUS1
2.90
-0.01 (-0.34%)
-0.01 (-0.34%)
Upgrade to Real-Time
Afterhours (Closed)
Low
0.81
High
9.80
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Atossa Therapeutics Inc | ATOS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.01 | -0.34% | 2.90 | 00:00:07 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.93 | 2.86 | 3.03 | 2.86 | 2.91 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 1.46 | 2.90 | 1.44 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 14,147 | 4,710,972 | $ 2.95 | $ 13,877,153 | - | 0.81 - 9.80 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:54:45 | formt | 200 | $ 2.90 | USD |
Period:
Draw Mode:
Atossa Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 367.21M | 126.62M | 126.57M | $ - | $ - | -1.97 | -2.30 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | -164.58k | 0.40% |
Atossa Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ATOS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.27 | 3.33 | 2.835 | 3.03 | 3,439,567 | -0.37 | -11.31% |
| 1 Month | 3.41 | 3.58 | 2.835 | 3.26 | 4,089,987 | -0.51 | -14.96% |
| 3 Months | 4.05 | 4.57 | 2.75 | 3.44 | 7,111,980 | -1.15 | -28.4% |
| 6 Months | 1.86 | 9.80 | 1.48 | 4.67 | 14,029,412 | 1.04 | 55.91% |
| 1 Year | 2.15 | 9.80 | 0.81 | 3.57 | 13,880,957 | 0.75 | 34.88% |
| 3 Years | 1.47 | 9.80 | 0.755 | 3.59 | 5,147,458 | 1.43 | 97.28% |
| 5 Years | 21.72 | 31.20 | 0.755 | 4.23 | 3,693,881 | -18.82 | -86.65% |
Atossa Therapeutics Description
| Atossa Therapeutics Inc is a clinical-stage pharmaceutical company operating in the US. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use. |
